Variant report
Variant | nsv823178 |
---|---|
Chromosome Location | chr5:111938702-111942771 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs142896585 | chr5:111938729-111938730 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs6887003 | chr5:111938738-111938739 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs376959572 | chr5:111938751-111938752 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs377660862 | chr5:111938780-111938781 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs114936043 | chr5:111938785-111938786 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs575905160 | chr5:111938796-111938797 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs370898547 | chr5:111938799-111938800 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs182834358 | chr5:111938830-111938831 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs570899516 | chr5:111938836-111938837 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs534938608 | chr5:111938844-111938845 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs553496831 | chr5:111938873-111938874 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs62365801 | chr5:111938877-111938878 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs115317137 | chr5:111938893-111938894 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs542461556 | chr5:111938900-111938901 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs114362589 | chr5:111938967-111938968 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs528761501 | chr5:111938968-111938969 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs540954827 | chr5:111938994-111938995 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs116485773 | chr5:111938998-111938999 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs563866602 | chr5:111939006-111939007 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs147423440 | chr5:111939145-111939146 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs6594639 | chr5:111939151-111939152 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs116368925 | chr5:111939152-111939153 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs550397956 | chr5:111939213-111939214 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs529178942 | chr5:111939328-111939329 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs550931733 | chr5:111939332-111939333 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs140728854 | chr5:111939352-111939353 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs530954261 | chr5:111939369-111939370 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs115596255 | chr5:111939379-111939380 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs80338966 | chr5:111939386-111939387 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs566349416 | chr5:111939456-111939457 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs535089962 | chr5:111939475-111939476 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs187954960 | chr5:111939499-111939500 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs533812986 | chr5:111939500-111939501 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs535645062 | chr5:111939613-111939614 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs13162426 | chr5:111939614-111939615 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs7380750 | chr5:111939618-111939619 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs4957657 | chr5:111939637-111939638 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs557703542 | chr5:111939652-111939653 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs572876471 | chr5:111939665-111939666 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs368003756 | chr5:111939673-111939674 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs13162066 | chr5:111939678-111939679 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs144648217 | chr5:111939689-111939690 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs370470683 | chr5:111939704-111939705 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs6421846 | chr5:111939731-111939732 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs544396431 | chr5:111939743-111939744 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs144677954 | chr5:111939746-111939747 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs533227706 | chr5:111939778-111939779 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs552625290 | chr5:111939787-111939788 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs148544717 | chr5:111939805-111939806 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs557080098 | chr5:111939879-111939880 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Colorectal cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Prostate cancer | 16461572 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:111930800-111940000 | Weak transcription | Brain Inferior Temporal Lobe | brain |
2 | chr5:111931400-111940000 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
3 | chr5:111935400-111939000 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
4 | chr5:111938800-111941000 | Enhancers | Primary monocytes fromperipheralblood | blood |
5 | chr5:111938800-111941000 | Enhancers | Primary neutrophils fromperipheralblood | blood |
6 | chr5:111938800-111941200 | Enhancers | Monocytes-CD14+_RO01746 | blood |
7 | chr5:111939000-111941000 | Enhancers | Cortex derived primary cultured neurospheres | brain |
8 | chr5:111940000-111940600 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
9 | chr5:111940000-111941200 | Enhancers | Brain Inferior Temporal Lobe | brain |
10 | chr5:111940000-111941200 | Enhancers | Fetal Intestine Large | intestine |
11 | chr5:111940000-111941400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
12 | chr5:111940200-111941000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
13 | chr5:111940200-111941000 | Enhancers | HepG2 | liver |
14 | chr5:111940400-111941000 | Enhancers | Liver | Liver |
15 | chr5:111940400-111941200 | Enhancers | Brain Anterior Caudate | brain |
16 | chr5:111940600-111941000 | Enhancers | Brain Hippocampus Middle | brain |
17 | chr5:111940600-111941000 | Enhancers | Brain Substantia Nigra | brain |
18 | chr5:111941000-111943600 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
19 | chr5:111941000-111952600 | Weak transcription | Right Atrium | heart |
20 | chr5:111941200-111943400 | Weak transcription | Fetal Intestine Large | intestine |
21 | chr5:111941400-111943200 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |